Pfizer, Moderna Take Different Paths as Vaccine Boom Ends

Pfizer is trying to add $25 billion to its 2030 revenue through acquisitions. Dan Kitwood – WPA Pool/Getty Images Text size Pfizer ’s $5.4 billion deal to acquire the biotech Global Blood Therap...

Palantir, Signify Health, Global Blood Therapeutics and more

Take a look at some of the biggest movers in the premarket: Palantir (PLTR) – The data analytics company’s stock plunged 15.6% in premarket trading after it reported an unexpected quarterly loss...